文献速递垂体与肾上腺疾病肥胖与代谢综合征

肥胖是特发性醛固酮增多症的关键因素

Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

本研究基于日本多中心原发性醛固酮增多症数据库,回顾性比较516例醛固酮腺瘤(APA)与1015例特发性醛固酮增多症(IHA)患者的肥胖和代谢紊乱情况,并与274例原发性高血压(EHT)患者对照。结果显示IHA患者肥胖患病率显著高于APA和EHT,且甘油三酯和HbA1c在IHA中更高,提示肥胖相关因素参与IHA发病。

要点

  • IHA患者肥胖患病率显著高于APA和EHT患者。
  • IHA患者甘油三酯和HbA1c显著高于APA患者。
  • IHA患者血浆醛固酮浓度低于APA患者。

核心结论

  • IHA患者尽管血浆醛固酮浓度较低,但更倾向于肥胖,提示肥胖相关因素参与IHA发病。

研究设计与样本

  • 回顾性横断面研究,基于日本多中心原发性醛固酮增多症研究数据库,纳入516例APA和1015例IHA患者,并与274例EHT患者对照。

主要发现

  • APA患者血浆醛固酮浓度显著高于IHA患者。
  • 调整临床背景后,IHA患者肥胖患病率显著高于APA或EHT患者。
  • IHA与APA患者糖尿病和血脂异常患病率无显著差异,但IHA患者甘油三酯和HbA1c显著更高。
  • 两种亚型中代谢参数与血浆醛固酮浓度均无显著相关性。

临床怎么用

  • 对IHA患者应关注肥胖及代谢异常,评估并管理体重和代谢指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Recently, the relationship between primary aldosteronism (PA) and various metabolic disorders, including obesity, diabetes mellitus, and dyslipidemia, has been discussed. However, in PA, aldosterone-producing adenoma (APA) and idiopathic hyperaldosteronism (IHA) have different etiologies. OBJECTIVE: Our objectives were to clarify differences in obesity and metabolic disorders between APA and IHA and to gain insight in the pathogenesis of IHA. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cross-sectional study. We assessed the PA database established by the multicenter Japan Primary Aldosteronism Study. For comparative analysis, data were also collected from 274 patients with essential hypertension (EHT). MAIN OUTCOME MEASURES: We compared prevalences of obesity and metabolic disorders between patients with APA and patients with IHA. Comparisons with sex-, age-, and blood pressure-matched patients with EHT were also performed. Correlations between metabolic parameters and plasma aldosterone concentrations (PACs) in each subtype were analyzed. RESULTS: Analysis of 516 patients with APA and 1015 patients with IHA revealed PACs were significantly higher in patients with APA than patients with IHA. By contrast, after we adjusted for clinical backgrounds, the prevalence of obesity was significantly higher in patients with IHA than in patients with APA or EHT. Although the prevalences of diabetes mellitus and dyslipidemia did not significantly differ between patients with IHA and patients with APA, triglyceride and HbA1c were significantly higher in patients with IHA than in patients with APA. There was no significant correlation between metabolic parameters and PACs in either subtype. CONCLUSIONS: Patients with IHA tend to be obese despite lower PACs than in patients with APA. The present results suggest that obesity-related factors contribute to the pathogenesis of IHA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ohno Y, Sone M, Inagaki N, et al. Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism. J Clin Endocrinol Metab. 2018. PMID: 30165444. doi:10.1210/jc.2018-00866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。